Analysis of pathological complete response (PCR) and impact of modifiable risk factors on the premature discontinuation of pertuzumab use in early stage HER-2 breast cancer: A retrospective single-institutional study
Anwar, Khurram, Khatri, Jai Kumar, Masoudi, Mohd, Abdallah, Mahmoud, Tahboub, Ihab, Nwanwene, Kemnasom, Howide, Eldib, Tria Tirona, Maria Rosalia
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article